Madrigal Pharmaceuticals Ownership | Who Owns Madrigal Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Madrigal Pharmaceuticals Ownership Summary

Madrigal Pharmaceuticals is owned by 13.55% institutional investors, 7.54% insiders, and 78.91% retail investors. Janus henderson group is the largest institutional shareholder, holding 10.16% of MDGL shares. Janus Concentrated Growth CF is the top mutual fund, with 2.72% of its assets in Madrigal Pharmaceuticals shares.

MDGL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Madrigal Pharmaceuticals	13.55%	7.54%	78.91%
Sector	Healthcare Stocks	42.54%	10.82%	46.64%
Industry	Biotech Stocks	45.21%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Janus henderson group	2.21M	10.16%	$681.37M
Baker bros. advisors lp	2.14M	9.64%	$982.31M
Rtw investments, lp	1.99M	8.98%	$914.42M
Paulson	1.91M	8.59%	$874.90M
Avoro capital advisors	1.83M	8.25%	$840.72M
Vanguard group	1.81M	8.16%	$831.12M
Blackrock	1.43M	7.14%	$399.86M
Blackrock funding, inc. /de	1.56M	7.02%	$715.38M
State street	658.10K	2.96%	$301.84M
Geode capital management	446.23K	2.01%	$204.70M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Paulson	1.91M	29.46%	$874.90M
Tao capital management lp	41.00K	14.22%	$18.81M
Rtw investments, lp	1.99M	11.27%	$914.42M
Avoro capital advisors	1.83M	10.87%	$840.72M
Nan fung group	11.87K	9.13%	$5.45M
Ally bridge group (ny)	32.66K	9.12%	$14.98M
Bioimpact capital	100.42K	7.54%	$46.06M
Tri locum partners lp	67.71K	7.14%	$31.05M
Baker bros. advisors lp	2.14M	7.10%	$982.31M
University of wisconsin foundation	13.01K	5.05%	$5.97M

Top Buyers

Holder	Shares	% Assets	Change
Wellington management group llp	404.45K	0.03%	397.08K
Blackrock	1.43M	0.01%	216.86K
Goldman sachs group	386.10K	0.02%	196.26K
Baker bros. advisors lp	2.14M	7.10%	165.68K
Blackrock funding, inc. /de	1.56M	0.01%	120.99K

Top Sellers

Holder	Shares	% Assets	Change
Holocene advisors, lp	-	-	-390.55K
Ubs group	217.34K	0.02%	-288.37K
Adage capital partners gp	88.50K	0.06%	-287.66K
Janus henderson group	2.21M	0.35%	-269.77K
Ra capital management	-	-	-204.50K

New Positions

Holder	Shares	% Assets	Change	Value
Alkeon capital management	120.00K	0.08%	120.00K	$55.04M
Driehaus capital management	115.97K	0.38%	115.97K	$53.19M
Norges bank	115.09K	0.00%	115.09K	$35.51M
Iron triangle partners lp	58.38K	3.81%	58.38K	$26.78M
Ally bridge group (ny)	32.66K	9.12%	32.66K	$14.98M

Sold Out

Holder	Change
Atlas capital advisors	-1.00
Fifth third bancorp	-1.00
True wealth design	-1.00
Ronald blue trust	-1.00
Cva family office	-2.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	135	-57.68%	3,008,956	-86.78%	13	0.13%	69	-51.75%	40	-63.64%
Jun 30, 2025	325	-4.69%	23,563,853	0.96%	106	0.95%	144	-20.00%	111	18.09%
Mar 31, 2025	341	6.90%	23,616,052	2.83%	106	0.96%	178	4.09%	96	26.32%
Dec 31, 2024	300	5.63%	19,963,834	-11.66%	91	0.85%	157	20.77%	75	-14.77%
Sep 30, 2024	281	-1.75%	22,596,992	-0.11%	103	0.81%	128	-20.99%	87	31.82%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Janus Concentrated Growth CF	604.92K	2.72%	-27.38K
Janus Henderson Forty S	604.92K	2.72%	-
Vanguard Total Stock Mkt Idx Inv	598.65K	2.69%	-12.61K
Vanguard US Total Market Shares ETF	578.31K	2.62%	388.00
Vanguard Small Cap Index	458.31K	2.06%	-2.70K
iShares Russell 2000 ETF	407.25K	1.83%	-
Janus Henderson Opportunistic Alpha MA	319.65K	1.47%	319.62K
Janus Henderson US Opportunistic Alpha	304.98K	1.37%	-52.93K
Janus Henderson Contrarian D	304.98K	1.37%	-
SPDR® S&P Biotech ETF	299.46K	1.34%	670.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 10, 2025	FRIEDMAN PAUL A	-	Sell	$2.38M
Dec 10, 2025	FRIEDMAN PAUL A	-	Sell	$224.94K
Dec 10, 2025	FRIEDMAN PAUL A	-	Sell	$293.45K
Dec 10, 2025	FRIEDMAN PAUL A	-	Sell	$341.79K
Dec 10, 2025	FRIEDMAN PAUL A	-	Sell	$3.97M

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	70
2025 Q3	54	78
2025 Q2	-	-
2025 Q1	-	56
2024 Q4	-	10

MDGL Ownership FAQ

Who Owns Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals shareholders are primarily institutional investors at 13.55%, followed by 7.54% insiders and 78.91% retail investors. The average institutional ownership in Madrigal Pharmaceuticals's industry, Biotech Stocks , is 45.21%, which Madrigal Pharmaceuticals falls below.

Who owns the most shares of Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals’s largest shareholders are Janus henderson group (2.21M shares, 10.16%), Baker bros. advisors lp (2.14M shares, 9.64%), and Rtw investments, lp (1.99M shares, 8.98%). Together, they hold 28.78% of Madrigal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Madrigal Pharmaceuticals?

Yes, BlackRock owns 7.14% of Madrigal Pharmaceuticals, totaling 1.43M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 399.86M$. In the last quarter, BlackRock increased its holdings by 216.86K shares, a 17.92% change.

Who is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Paulson is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 29.46% of its assets in 1.91M Madrigal Pharmaceuticals shares, valued at 874.9M$.

Who is the top mutual fund holder of Madrigal Pharmaceuticals shares?

Janus Concentrated Growth CF is the top mutual fund holder of Madrigal Pharmaceuticals shares, with 2.72% of its total shares outstanding invested in 604.92K Madrigal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools